- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06488092
IC-CS Risk: Patient Outcomes
September 2, 2025 updated by: Rebecca Feldman Hamm, University of Pennsylvania
Implementation of Calculated Cesarean Section Risk Study: Patient-focused Outcomes
This study is looking at the impact of the implementation of a cesarean risk calculator on cesarean delivery and maternal morbidity rates.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
In this study a cesarean risk calculator will be instituted as a part of standard of care in a randomized rollout at 14 labor and delivery clinical sites across 4 institutions.
The leadership at all of the sites have planned to implement this intervention for routine use at both sites.
This study will evaluate cesarean delivery rates and maternal morbidity before and after implementation at each site.
Study Type
Interventional
Enrollment (Estimated)
20000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
Clinton Township, Michigan, United States, 48038
- Henry Ford Macomb Hospital
-
Detroit, Michigan, United States, 48202
- Henry Ford Hospital
-
Lansing, Michigan, United States, 48912
- E.W. Sparrow Hospital
-
-
New Jersey
-
Plainsboro, New Jersey, United States, 08536
- Princeton Medical Center
-
-
Ohio
-
Akron, Ohio, United States, 44307
- Akron General
-
Cleveland, Ohio, United States, 44111
- Fairview Hospital
-
Mayfield Heights, Ohio, United States, 44124
- Hillcrest Hospital
-
-
Pennsylvania
-
Lancaster, Pennsylvania, United States, 17602
- Lancaster General Health
-
West Chester, Pennsylvania, United States, 19380
- Chester County Hosptial
-
-
Utah
-
Logan, Utah, United States, 84341
- Logan Regional Hospital-Intermountain Healthcare
-
Ogden, Utah, United States, 84403
- McKay-Dee Hospital
-
Riverton, Utah, United States, 84065
- Riverton Hospital-Intermountain Healthcare
-
Salt Lake City, Utah, United States, 84132
- University of Utah Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Study Population
See eligibility criteria above.
Description
Inclusion Criteria:
All postpartum patients who were eligible for cesarean risk calculator utilization:
- delivery of a full-term (greater than or equal to 37 weeks) singleton gestation after presenting
- with intact membranes
- undergoing an induction of labor from cervical dilation less than or equal to 2cm
Exclusion Criteria:
Postpartum patient who had a prior pregnancy resulting in Cesarean delivery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Pre-utilization of cesarean risk calculator
The time prior to the implementation of the cesarean risk calculator at the labor and delivery unit.
|
|
|
Active Comparator: Implementation of cesarean risk calculator
The cesarean risk calculator will be incorporated into routine care at the site
|
The cesarean risk calculator will be incorporated into routine care at the site
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cesarean delivery rate (for any indication)
Time Frame: at time of delivery
|
at time of delivery
|
|
|
Maternal morbidity
Time Frame: from delivery to 30 days postpartum
|
one or more of the following: endometritis, postpartum hemorrhage greater than or equal to one liter, wound infection requiring antibiotics, venous thromboembolism, hysterectomy, intensive care unit admission, readmission within 30 days, and death
|
from delivery to 30 days postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neonatal morbidity
Time Frame: delivery admission
|
one or more of the following: severe respiratory distress, neonatal resuscitation outside of delivery room, and sepsis
|
delivery admission
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Rebecca Hamm, MD, University of Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2024
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2027
Study Registration Dates
First Submitted
June 25, 2024
First Submitted That Met QC Criteria
July 3, 2024
First Posted (Actual)
July 5, 2024
Study Record Updates
Last Update Posted (Estimated)
September 10, 2025
Last Update Submitted That Met QC Criteria
September 2, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 854955
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Delivery
-
Charite University, Berlin, GermanyCompletedCesarean Section Complications | Cesarean Delivery Affecting Newborn | Cesarean Delivery Affecting FetusGermany
-
Columbia UniversityNot yet recruitingDexmedetomidine | Postoperative Analgesia | Cesarean Delivery | Cesarean Delivery; Neuraxial Opioids | Clonidine | Spinal Anesthesia for Cesarean SectionUnited States
-
Insel Gruppe AG, University Hospital BernRecruitingCesarean Section | Delivery, Obstetric | Obstetric DeliverySwitzerland
-
Rambam Health Care CampusRecruitingCesarean Delivery Affecting Fetus | Delivery ComplicationIsrael
-
Ege UniversityNot yet recruitingCesarean DeliveryTurkey (Türkiye)
-
Women's Hospital School Of Medicine Zhejiang UniversityRecruiting
-
Pujic BorislavaUnknownCesarean DeliverySerbia
-
Columbia UniversityCompletedCesarean DeliveryUnited States
-
S. Anna HospitalUnknownCesarean DeliveryItaly
-
University of British ColumbiaCompletedCesarean DeliveryCanada
Clinical Trials on Cesarean Risk Calculator
-
Carle Foundation HospitalNot yet recruitingPain Management | Patient Satisfaction | Gynecologic ProceduresUnited States
-
The Cleveland ClinicCompletedVenous ThromboembolismUnited States
-
Medstar Health Research InstituteCompletedPelvic Organ Prolapse | Stress Urinary Incontinence | SatisfactionUnited States
-
Duke UniversityWithdrawn
-
Norwegian University of Science and TechnologyNorwegian Cancer SocietyRecruiting
-
European Association of Urology Research FoundationNational Cancer Institute (NCI); UMC Utrecht; Erasmus Medical Center; University... and other collaboratorsEnrolling by invitationProstate CancerIreland, Lithuania, Poland, Spain
-
prof. dr. Frans B. PlötzDutch Society of Pediatrics; Zorgevaluatie Nederland; Care4Neo; everywhereIMRecruitingEOS | Early-Onset Sepsis, NeonatalNetherlands
-
Nepal Mediciti HospitalCompleted
-
Brigham and Women's HospitalCompletedKnee Osteoarthritis
-
The Cleveland ClinicNational Institute on Aging (NIA)Enrolling by invitationCognitive Risk AssessmentUnited States